REGENERON PHARMACEUTICALS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Regeneron Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2011 to Q3 2024.
  • Regeneron Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 108M shares, a 1.69% increase year-over-year.
  • Regeneron Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 107M shares, a 0.37% decline from 2022.
  • Regeneron Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 107M shares, a 1.33% increase from 2021.
  • Regeneron Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 106M shares, a 1.77% decline from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 108M +1.8M +1.69% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 108M +1.1M +1.03% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 108M +700K +0.65% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 107M -400K -0.37% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-05
Q3 2023 106M -600K -0.56% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 107M -900K -0.83% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 107M +300K +0.28% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 107M +1.4M +1.33% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-05
Q3 2022 107M +700K +0.66% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 108M +2.9M +2.76% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 107M +1.4M +1.33% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 106M -1.9M -1.77% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-05
Q3 2021 106M +700K +0.66% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 105M -4.6M -4.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 105M -4.4M -4.01% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 108M -1.6M -1.47% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-06
Q3 2020 106M -3.9M -3.57% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 110M +400K +0.37% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 110M +900K +0.83% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 109M +1.3M +1.21% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-07
Q3 2019 109M +1.4M +1.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 109M +1.4M +1.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 109M +1.3M +1.21% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 108M +1.6M +1.51% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-08
Q3 2018 108M +1.29M +1.21% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 108M +1.77M +1.67% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 108M +2.03M +1.92% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 106M +1.6M +1.53% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-07
Q3 2017 107M +1.87M +1.79% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 106M +1.4M +1.34% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 106M +1.28M +1.23% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 105M +1.64M +1.59% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-07
Q3 2016 105M +1.49M +1.44% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 105M +1.75M +1.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 104M +2.06M +2.02% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 103M +2.45M +2.43% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-08
Q3 2015 103M +2.55M +2.53% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 103M +2.5M +2.49% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 102M +3.52M +3.56% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 101M +2.7M +2.75% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-09
Q3 2014 101M +2.57M +2.62% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 100M +2.69M +2.75% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-04
Q1 2014 98.7M +1.83M +1.89% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 97.9M +3.23M +3.41% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-11
Q3 2013 98.2M +3.21M +3.38% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-04
Q2 2013 97.7M +3.11M +3.29% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 96.9M +3.43M +3.67% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 94.7M +4.08M +4.5% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-12
Q3 2012 95M +3.97M +4.36% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-05
Q2 2012 94.6M +4.15M +4.59% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 93.4M +4.28M +4.81% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-03
Q4 2011 90.6M Oct 1, 2011 Dec 31, 2011 10-K 2014-02-13
Q3 2011 91M Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-24
Q2 2011 90.4M Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-25
Q1 2011 89.2M Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.